HST Global (HST Global) ROCE % : 0.00% (As of Dec. 2023)

View and export this data going back to 2002. Start your Free Trial

What is HST Global ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. HST Global's annualized ROCE % for the quarter that ended in Dec. 2023 was 0.00%.

HST Global ROCE % Historical Data

The historical data trend for HST Global's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HST Global ROCE % Chart

HST Global Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

HST Global Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															-	-	-	-	-

HST Global ROCE % Calculation

HST Global's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-0.141	/	( ( (0 - 0.446)	+	(0.002 - 0.594) )	/ 2 )
	=	-0.141	/	( (-0.446	+	-0.592)	/ 2 )
	=	-0.141	/	-0.519
	=	27.17 %

HST Global's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	-0.14	/	( ( (0.002 - 0.557)	+	(0.002 - 0.594) )	/ 2 )
	=	-0.14	/	( ( -0.555	+	-0.592 )	/ 2 )
	=	-0.14	/	-0.5735
	=	0 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

HST Global (OTCPK:HSTC) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

HST Global ROCE % Related Terms

Thank you for viewing the detailed overview of HST Global's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

HST Global (HST Global) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HST Global Inc (OTCPK:HSTC) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

150 Research Drive, Hampton, VA, USA, 23666

Website

http://www.hstglobal.com

HST Global Inc is an integrated health and wellness biotechnology company. It is engaged in developing and acquiring a network of Wellness Centers that are focused on the homeopathic and alternative treatment of late-stage cancer. Further, it primarily focuses on homeopathic and alternative product candidates that are undergoing or have already completed clinical testing. The activities are generally carried out through the region of the United States.

Executives

Wesley D. Tate	officer: CFO and Secretary	C/O HEALTH SOURCE TECHNOLOGIES, INC., 150 RESEARCH DRIVE, HAMPTON VA 23666
Ronald R. Howell	director, officer: CEO and Chairman	C/O HEALTH SOURCE TECHNOLOGIES, INC., 150 RESEARCH DRIVE, HAMPTON VA 23666
Pnc Labs Inc	10 percent owner	429 W PLUMB LANE, RENO NV 89509
Chun Ka Tsun	director, 10 percent owner, officer: CEO	TG WANASPORTS MANAGEMENT HOLDINGS, 8/F NO 211 JOHNSTON ROAD, WAN CHAI K3 00000
Chen Tsz King	10 percent owner	FUGU ENTERPRISE INC, UNIT A 8TH FLOOR NO 65 SING WOOD ROAD, HAPPY VALLEY K3 00000
Li Sze Tang	10 percent owner	FLAT G, 8/FL TOWER THREE, THE WATERFRONT, 1 AUSTIN ROAD WEST, TST K3 00000
Andre E Todd	director	746 HILLGIRT CIRCLE, OAKLAND CA 94610
Aaron Etra	director	1350 AVE OF AMERICAS, 29TH FLOOR, NEW YORK NY 10019
Communications Holding Corp	10 percent owner
Alan Lew	director, 10 percent owner, officer: President	2 DOGWOOD DR, SCARSDALE NY 10583

HST Global (HST Global) Headlines

From GuruFocus

HST Global, Inc. Announces Entering into an Agreement to Purchase a Financial Services Revenue Sharing Contract.

By Marketwired Marketwired • 08-23-2019